Article
US Senator Elizabeth Warren expresses 'disappointment' in FTC's Amgen decision
Rating:
0.0
Views:
52
Likes:
1
Library:
1
Senator Elizabeth Warren, an antitrust hawk, expressed disappointment with the U.S. Federal Trade Commission's decision to allow pharmaceutical firm Amgen to move forward with its acquisition of Horizon Therapeutics.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value